Sumitomo Pharma Co.,Ltd.

4506

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-31FY2027 Q1

Revenue

4747.9100M JPY

YoY +14.1%

Operating Income

181.9100M JPY

YoY -10.8%

Net Income

1126.6100M JPY

YoY +496.0%

EPS

39.0JPY

YoY +38.3%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

5600.4億円

3313.1億円

1025.9億円

-1261.4億円

-3548.6億円

Rev: 5600.4億円Op: 602.3億円NI: 564.1億円

Rev: 5555.4億円Op: -769.8億円NI: -745.1億円

Rev: 3145.6億円Op: -3548.6億円NI: -3149.7億円

Rev: 3988.3億円Op: 288億円NI: 236.3億円

Rev: 4532.9億円Op: 1073.4億円NI: 1068.7億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income22.1%

Revenue Progress129500M

Revenue Forecast540000M

Net Income Progress17000M

Net Income Forecast77000M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan